CPT1A and metabolic dysfunction-associated steatotic liver disease: Meanwhile, in humans with NAFLD, there is a downregulation of carnitine palmitoyltransferase 1α (Cpt1a) and acyl-CoA oxidase 1 (Acox1), leading to decreased transcriptional activity of PPARα (Li et al., 2022).